J. Alan Menius

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Kathleen K. Brown, Brad R. Henke, Steven G. Blanchard et al. · Diabetes · 1999 · 168 citations

Insulin Signaling, Peroxisome Proliferator-activated Receptor, Metabolic Syndrome +16

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation

Les Sekut, David P. Yarnall, Stephen A. Stimpson et al. · Clinical & Experimental Immunology · 1995 · 123 citations · Full text

Inflammation, Inflammatory Responses, Cytokine +15

Anti-inflammatory activity of salmeterol: down-regulation of cytokine production

Les Sekut, Brian Champion, Kimberly Page et al. · Clinical & Experimental Immunology · 1995 · 112 citations

Inflammation, Cytokine, Intracellular Camp Levels +11

Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.

James G. Conway, Jean A. Wakefield, Roger H. Brown et al. · The Journal of Experimental Medicine · 1995 · 108 citations · Full text

Matrix Metalloproteinase Inhibitor, Sclerostin, Adjuvant Arthritis +16

Social Media Listening for Routine Post-Marketing Safety Surveillance

Gregory Powell, Harry Seifert, Tjark Reblin et al. · Drug Safety · 2016 · 97 citations

Post-marketing Surveillance, Social Media, Social Medium Monitoring +6